HCC Trials Spur Treatment Landscape Forward - Hallo friend NEWS AN INSPIRATION, In the article you read this time with the title HCC Trials Spur Treatment Landscape Forward, we have prepared well for this article you read and download the information therein. hopefully fill posts Article ECONOMY, Article HEALTH, Article POLITICS, Article SPORTS, Article TRAVELING, Article UPDATE, we write can understand. Well, happy reading.

Titre : HCC Trials Spur Treatment Landscape Forward
link : HCC Trials Spur Treatment Landscape Forward

HCC Trials Spur Treatment Landscape Forward

HCC Trials Spur Treatment Landscape Forward
Caroline Seymour
Published: Wednesday, Apr 11, 2018

Clinical trials continue to investigate the use of immunotherapy agents in advanced hepatocellular carcinoma (HCC), especially with the phase III CheckMate-459 trial in which nivolumab (Opdivo) is being compared with sorafenib (Nexavar) in the frontline setting.

“CheckMate-459 has completed accrual and will likely be the next big story in HCC because it has the potential to change not only the standard of care, but the entire treatment landscape,” says R. Kate Kelley, MD.

Continue Reading: https://www.onclive.com/web-exclusives/hcc-trials-spur-treatment-landscape-forward

Thus articles HCC Trials Spur Treatment Landscape Forward

that is all articles HCC Trials Spur Treatment Landscape Forward This time, hopefully can provide benefits to you all. Okay, see you in another article post.

You are now reading the article HCC Trials Spur Treatment Landscape Forward the link address https://newsaninpiration.blogspot.com/2018/04/hcc-trials-spur-treatment-landscape.html

Tweet

Subscribe to receive free email updates: